Autopsy report · NCT04201782

Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T

“There have been no significant safety issues in any subjects exposed between 7.5 and 13.5 years ago to either SB-728-T or SB-728mR-T, including no delayed adverse events related to the investigational product.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 years 9 months after it had already started.
• Ran for about 12 years 4 months before it stopped.
• 38 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Sangamo Therapeutics

Sponsor type

Industry

Conditions

HIV-1-infection

Interventions

There are no disallowed treatments

Participants

38

Sites

4

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.